HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
(Sponsored) Patient-monitoring AI tools' demo to debut at HIMSS26
Latest Videos

(Sponsored) Patient-monitoring AI tools' demo to debut at HIMSS26

0:57

John Chuang, ONYX Healthcare president, says the company's remote monitoring AI products can be customized to enhance providers' existing workflows and support care coordination.

Read More
Read Less

Latest Videos - Similar Videos View more in Latest Videos

4:20

A phased approach to seamless RPM data flow

Switching cardiology patients to Bluetooth-enabled medical devices that send data to patient portals is helping to reduce chronic care complexities, says Sutter Health CCIO Dr. Richard Milani and Patient Experience R&D lead Trevor Berceau.

A phased approach to seamless RPM data flow
Switching cardiology patients to Bluetooth-enabled medical devices that send data to patient portals is helping to reduce chronic care complexities, says Sutter Health CCIO Dr. Richard Milani and Patient Experience R&D lead Trevor Berceau.
4:20
3:33

Researching Down syndrome pregnancy and maternal decline

Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, discusses the lab's study on the mechanistic link between pregnancy with a Down syndrome fetus and an elevated risk of maternal cognitive decline.

Researching Down syndrome pregnancy and maternal decline
Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, discusses the lab's study on the mechanistic link between pregnancy with a Down syndrome fetus and an elevated risk of maternal cognitive decline.
3:33
7:52

AI is driving down clinical denial rates

Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.

AI is driving down clinical denial rates
Todd Van Meter, CEO of Accuity, says that when partnering with clients, initial clinical denial rates are nearly cut in half and following an appeals process using an AI-driven platform, the final denial rates end up at 1% to 1.5%.
7:52